The U.S. is facing an opioid-related public health crisis, and states have responded with a range of policies and initiatives, many of which are intended to decrease the widespread availability of opioid analgesics. Our understanding of the impact of these policies is still evolving, results of studies have been mixed, and no studies have examined to what extent policies have decreased potentially inappropriate prescribing while leaving likely appropriate prescribing untouched. To assess the impact of state policies and initiatives on overall opioid prescribing rates, likely appropriate prescribing, and potentially inappropriate prescribing, this project will produce empirical findings addressing these gaps using Medicare claims data for disabled beneficiaries, as well as IQVIA data which covers an estimated 88% of prescriptions filled at U.S. pharmacies. It will also examine how policies affect opioid prescription fills for historically underserved and high-risk populations. The results will inform state policymaking efforts related to the opioid crisis.

Public Health Relevance

This project will assess the impact of state policies designed to decrease the availability of opioid analgesics and to what extent policies decrease potentially inappropriate prescribing while leaving likely appropriate prescribing untouched. We will also examine the effect of state policies on opioid prescription fills by historically underserved and high-risk populations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA045055-03
Application #
10089429
Study Section
Community Influences on Health Behavior Study Section (CIHB)
Program Officer
Su, Shelley
Project Start
2019-03-15
Project End
2022-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
3
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Rand Corporation
Department
Type
DUNS #
006914071
City
Santa Monica
State
CA
Country
United States
Zip Code
90401